Occult Hepatitis C Virus Infection in Hemodialysis Patients: Examining the Evidence

American Journal of Kidney Diseases

Volumn 54, Issue 1, 2009, Pages 10-12

  Kamar, Nassim ^a   Nicot, Florence ^b   Izopet, Jacques ^b   Rostaing, Lionel ^a  

^a CHU RANGUEIL   (France)

^b CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; LIVER ENZYME; VIRUS RNA;

ANTIVIRAL THERAPY; CHRONIC KIDNEY DISEASE; DISEASE TRANSMISSION; EDITORIAL; ENZYME BLOOD LEVEL; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEPATITIS C; HISTOPATHOLOGY; HOSPITAL INFECTION; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; KIDNEY TRANSPLANTATION; LIVER BIOPSY; LIVER FIBROSIS; LIVER INJURY; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; PERIPHERAL BLOOD MONONUCLEAR CELL; RNA REPLICATION; ULTRACENTRIFUGATION; VIRUS REPLICATION; VIRUS VIRULENCE;

ANTIBODIES, VIRAL; BIOPSY; HEPACIVIRUS; HEPATITIS C; HUMANS; INCIDENCE; KIDNEY DISEASES; LIVER; RENAL DIALYSIS; RNA, VIRAL;

EID: 67449164357     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.12.033     Document Type: Editorial

References (18)

1. Pereira B.J., and Levey A.S. Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int 51 (1997) 981-999
2. Izopet J., Sandres-Saune K., Kamar N., et al. Incidence of HCV infection in French hemodialysis units: A prospective study. J Med Virol 77 (2005) 70-76
3. National Kidney Foundation. Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int Suppl (2008) S1-S99
4. Guh J.Y., Lai Y.H., Yang C.Y., et al. Impact of decreased serum transaminase levels on the evaluation of viral hepatitis in hemodialysis patients. Nephron 69 (1995) 459-465
5. Fabrizi F., Lunghi G., Andrulli S., et al. Influence of hepatitis C virus (HCV) viraemia upon serum aminotransferase activity in chronic dialysis patients. Nephrol Dial Transplant 12 (1997) 1394-1398
6. Espinosa M., Martin-Malo A., Alvarez de Lara M.A., Soriano S., and Aljama P. High ALT levels predict viremia in anti-HCV-positive HD patients if a modified normal range of ALT is applied. Clin Nephrol 54 (2000) 151-156
7. Carreno V. Occult hepatitis C virus infection: A new form of hepatitis C. World J Gastroenterol 12 (2006) 6922-6925
8. Pardo M., Lopez-Alcorocho J.M., Castillo I., Rodriguez-Inigo E., Perez-Mota A., and Carreno V. Effect of anti-viral therapy for occult hepatitis C virus infection. Aliment Pharmacol Ther 23 (2006) 1153-1159
9. Carreno V., Bartolomé J., Castillo I., and Quiroga J.A. Occult hepatitis B virus and hepatitis C virus infections. Rev Med Virol 18 (2008) 139-157
10. Bartolomé J., Lopez-Alcorocho J.M., Castillo I., et al. Ultracentrifugation of serum samples allows detection of hepatitis C virus RNA in patients with occult hepatitis C. J Virol 81 (2007) 7710-7715
11. Castillo I., Pardo M., Bartolomé J., et al. Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown. J Infect Dis 189 (2004) 7-14
12. Halfon P., Bourliere M., Ouzan D., et al. Occult hepatitis C virus infection revisited with ultrasensitive real-time PCR assay. J Clin Microbiol 46 (2008) 2106-2108
13. Pham T.N., King D., Macparland S.A., et al. Hepatitis C virus replicates in the same immune cell subsets in chronic hepatitis C and occult infection. Gastroenterology 134 (2008) 812-822
14. Pham T.N., and Michalak T.I. Occult persistence and lymphotropism of hepatitis C virus infection. World J Gastroenterol 14 (2008) 2789-2793
15. Hoare M., Gelson W.T., Rushbrook S.M., et al. Histological changes in HCV antibody-positive, HCV RNA-negative subjects suggest persistent virus infection. Hepatology 48 (2008) 1737-1745
16. Fowell A.J., Sheron N., and Rosenberg W.M. Renal hepatitis C in the absence of detectable serum or hepatic virus. Liver Int 28 (2008) 889-891
17. Barril G., Castillo I., Arenas M.D., et al. Occult hepatitis C virus infection among hemodialysis patients. J Am Soc Nephrol 19 (2008) 2288-2293
18. Kamar N., Toupance O., Buchler M., et al. Evidence that clearance of hepatitis C virus RNA after alpha-interferon therapy in dialysis patients is sustained after renal transplantation. J Am Soc Nephrol 14 (2003) 2092-2098